Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
$2,600.00
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. It is a component of bacterial immune systems that can cut DNA, and has been repurposed as a gene editing tool. CRISPR is important because it allows scientists to rewrite the genetic code in almost any organism. It is simpler, cheaper, and more precise than previous gene editing techniques. Moreover, it has a range of real-world applications, including curing genetic disease and creating drought-resistant crops. The global CRISPR technology market was estimated at USD 1,337 million in 2021 and is expected to hit USD 7,008 million by 2028, registering a CAGR of 26.7% from 2022 to 2028 as per the latest report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global CRISPR technology market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the CRISPR technology industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for CRISPR technology can be segmented by product: CRISPR products, CRISPR services. The CRISPR products segment held the largest revenue share in 2021. CRISPR technology market is further segmented by application: agricultural, biomedical, others. Among these, the biomedical segment was accounted for the highest revenue generator in 2021. Based on end user, the CRISPR technology market is segmented into: academic institutes and research centers, contract research organizations (CROs), pharmaceutical companies, biotechnology companies. On the basis of region, the CRISPR technology market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By product:
– CRISPR products
– CRISPR services
By application:
– agricultural
– biomedical
– others
By end user:
– academic institutes and research centers
– contract research organizations (CROs)
– pharmaceutical companies
– biotechnology companies
By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The CRISPR products market is further segmented into kits and enzymes, libraries, design tools, antibodies, others. Furthermore, the CRISPR services market has been categorized into gRNA design and vector construction, screening services, cell line engineering, others. The biomedical market is further divided into gene therapy, drug discovery, diagnostics.
The market research report covers the analysis of key stake holders of the global CRISPR technology market. Some of the leading players profiled in the report include Abcam, Inc., Agilent Technologies, Inc., Caribou Biosciences, Inc., Cellecta, Inc., CRISPR Therapeutics AG, Editas Medicine, Inc., GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Integrated DNA Technologies, Inc. (Danaher Corporation), Intellia Therapeutics, Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs GmbH, OriGene Technologies Inc., Precision BioSciences, Inc., Synthego Corporation, Thermo Fisher Scientific Inc., ToolGen, Inc., Transposagen Biopharmaceuticals Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global CRISPR technology market.
– To classify and forecast the global CRISPR technology market based on product, application, end user, region.
– To identify drivers and challenges for the global CRISPR technology market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global CRISPR technology market.
– To identify and analyze the profile of leading players operating in the global CRISPR technology market.
Why Choose This Report
– Gain a reliable outlook of the global CRISPR technology market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· CRISPR products
· CRISPR services
PART 6. MARKET BREAKDOWN BY APPLICATION
· Agricultural
· Biomedical
· Others
PART 7. MARKET BREAKDOWN BY END USER
· Academic institutes and research centers
· Contract research organizations (CROs)
· Pharmaceutical companies
· Biotechnology companies
PART 8. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 9. KEY COMPANIES
· Abcam, Inc.
· Agilent Technologies, Inc.
· Caribou Biosciences, Inc.
· Cellecta, Inc.
· CRISPR Therapeutics AG
· Editas Medicine, Inc.
· GeneCopoeia, Inc.
· GenScript Biotech Corporation
· Horizon Discovery Ltd.
· Integrated DNA Technologies, Inc. (Danaher Corporation)
· Intellia Therapeutics, Inc.
· Lonza Group Ltd.
· Merck KGaA
· New England Biolabs GmbH
· OriGene Technologies Inc.
· Precision BioSciences, Inc.
· Synthego Corporation
· Thermo Fisher Scientific Inc.
· ToolGen, Inc.
· Transposagen Biopharmaceuticals Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Abcam, Inc.
Agilent Technologies, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GenScript Biotech Corporation
Horizon Discovery Ltd.
Integrated DNA Technologies, Inc. (Danaher Corporation)
Intellia Therapeutics, Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs GmbH
OriGene Technologies Inc.
Precision BioSciences, Inc.
Synthego Corporation
Thermo Fisher Scientific Inc.
ToolGen, Inc.
Transposagen Biopharmaceuticals Inc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
CAGR (2022-2028) | 26.7% |
Pages | 93 |
Key Players | Abcam Inc., Agilent Technologies Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Integrated DNA Technologies Inc. (Danaher Corporation), Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs GmbH, OriGene Technologies Inc., Precision BioSciences Inc., Synthego Corporation, Thermo Fisher Scientific Inc., ToolGen Inc., Transposagen Biopharmaceuticals Inc. |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.